Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06508801 · ClinicalTrials.gov registry record · NA
Blood Flow Restriction for Optimizing Balance in Parkinson's Disease
A NA study of Parkinson's Disease and Parkinsonism, sponsored by The University of Texas Health Science Center at San Antonio.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06508801: Recruiting NA study of Parkinson's Disease and Parkinsonism, sponsored by The University of Texas Health Science Center at San Antonio.
NCT06508801 is a NA study of Parkinson's Disease and Parkinsonism that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 20 participants, below the 597-participant average among 6 other Parkinson's Disease and Parkinsonism trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06508801, a NA study of Parkinson's Disease and Parkinsonism, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to understand how reducing blood flow (BRT) during balance-challenging strengthening exercises (instability resistance training, or IRT) can help improve symptoms of Parkinson's disease.
Primary Outcome
The treatment will be considered acceptable if the dropout and significant adverse event rate is less than 20%, that is no more than 2 out of 10 participants in the treatment group either 1) drop out, 2) withdraw consent, or 3) have a significant adverse event (Grade 3 or higher on 5 point scale where 1 = mild, 2 = moderate, 3 = severe, 4 = life threatening, and 5 = death). Results will be reported as percentage of participants that dropped out.
Conditions Studied
Interventions
- OTHER Blood flow restriction training
- OTHER Instability Resistance Training
Study Locations (1)
Texas
- University of Texas Health Science Center at San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-01-07 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT06508801 shows while recruiting
NCT06508801 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 597-participant average among 6 other Parkinson's Disease and Parkinsonism trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Parkinson's Disease and Parkinsonism appearing as the primary indexed condition, and to 2 interventions - of which Blood flow restriction training is the first listed.
NCT06508801 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06508801 about?
NCT06508801 is a clinical study titled "Blood Flow Restriction for Optimizing Balance in Parkinson's Disease". This study is being done to understand how reducing blood flow (BRT) during balance-challenging strengthening exercises (instability resistance training, or IRT) can help improve symptoms of Parkinson's disease.
What is the current status of trial NCT06508801?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-01-07. Estimated completion is 2026-12.
What conditions does trial NCT06508801 study?
This clinical trial studies the following conditions: Parkinson's Disease and Parkinsonism.
What interventions are being tested in trial NCT06508801?
The interventions under investigation include: Blood flow restriction training (OTHER), Instability Resistance Training (OTHER).
Who is sponsoring clinical trial NCT06508801?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06508801 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease and Parkinsonism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sleep-specific DBS Therapy in Parkinson's Disease
RECRUITING · NA
-
Aim 3 Particle Swarm Optimization PIGD
RECRUITING · NA
-
Community Outreach for Palliative Engagement -- Parkinson Disease
ACTIVE NOT RECRUITING · NA
-
STEM-Parkinson's Disease
COMPLETED · NA
-
Colonoscopic Detection of Phosphorylated Alpha-synuclein for Parkinson's Diagnosis
RECRUITING
-
Trial of Parkinson's And Zoledronic Acid
ACTIVE NOT RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI